How Philanthropy Can Support Equitable Vaccine Distribution
Government and philanthropy can team up to distribute vaccines better
After nearly a year of living through the biggest public health crisis in generations—with 100 million people infected, 2 million people dead, and almost everyone’s lives disrupted—the world is desperate to see widespread vaccination against COVID-19. But the excitement of the Pfizer and Moderna vaccine approvals in December 2020 has since dampened after a rocky rollout to get those vaccines into people’s arms. It’s not enough to have a vaccine; it must be distributed effectively and equitably.
The good news is that vaccine distribution is picking up speed in many places. In the United States, President Joe Biden has promised to invest significant federal dollars to provide states with the resources they need to vaccinate their residents. But this support will take time to secure and distribute while the need remains urgent. One barrier is significant rates of vaccine hesitancy rates, driven in part by a history of medical exploitation and mistreatment toward people of color in the United States. A recent study showed that just 14 percent of Black Americans and 34 percent of Latinx Americans trust that a COVID-19 vaccine will be safe.
Moments like this call for public-private partnership. In my role managing public-private partnerships for the Office of the Governor in California, I’ve seen throughout the COVID-19 pandemic that working together and leveraging the strengths of both sectors has created significantly more impact than working alone.
Please select this link to read the complete article from SSIR.